AGM
IMA

Alpine Global Management’s ImageneBio Inc IMA Stock Holding History

Alpine Global Management’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,387
Closed -$107K – 290
2024
Q2 		$107K Buy
+5,387
New +$95.1K 0.02% 402

Other funds holding IMA

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return

Alpine Global Management's IMA Position: Q3 2024 in Review

Alpine Global Management sold out of ImageneBio Inc (IMA) in Q3 2024, closing a stake of 5,387 shares — an estimated $107K sold.

Alpine Global Management first reported a position in IMA in Q2 2024 and held it in 1 quarter. The position peaked at $107K in Q2 2024. 57 funds tracked by Wall St. Rank hold IMA as of Q3 2024.

  • Alpine Global Management reported no remaining ImageneBio Inc position as of Q3 2024 after selling out during the quarter.
  • Alpine Global Management sold 5,387 ImageneBio Inc shares in Q3 2024, an estimated $107K.
  • Alpine Global Management first reported a position in ImageneBio Inc in Q2 2024 and held it in 1 quarter.
  • Alpine Global Management's ImageneBio Inc position peaked at $107K in Q2 2024.
  • 57 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.